BACKGROUND: Clinical misdiagnosis, particularly at early disease stages, is a roadblock to finding new therapies for Lewy body disorders. Biopsy of a peripheral site might provide improved diagnostic accuracy. Previously, we reported, from both autopsy and needle biopsy, a high prevalence of submandibular gland synucleinopathy in Parkinson's disease (PD). Here, we report on an extension of these studies to subjects with dementia with Lewy bodies (DLB) and other Lewy body disorders in 228 autopsied subjects from the Arizona Study of Aging and Neurodegenerative Disorders. OBJECTIVE: To provide an estimate of the prevalence of histological synucleinopathy in the submandibular glands of subjects with PD and other Lewy body disorders. METHODS: Submandibular gland sections from autopsied subjects were stained with an immunohistochemical method for α-synuclein phosphorylated at serine 129. Included were 146 cases with CNS Lewy-type synucleinopathy (LTS), composed of 46 PD, 28 DLB, 14 incidental Lewy body disease (ILBD), 33 Alzheimer's disease with Lewy bodies (ADLB) and 2 with progressive supranuclear palsy and Lewy bodies (PSPLB). Control subjects included 79 normal elderly, 15 AD, 12 PSP, 2 conticobasal degeneration (CBD) and 2 multiple system atrophy (MSA). RESULTS: Submandibular gland LTS was found in 42/47 (89%) of the PD subjects, 20/28 (71%) DLB, 4/33 (12%) ADLB and 1/9 (11%) ILBD subjects but none of the 110 control subjects. CONCLUSIONS: These results provide support for further clinical trials of in vivo submandibular gland diagnostic biopsy for PD and DLB. An accurate peripheral biopsy diagnosis would assist subject selection for clinical trials and could also be used to verify other biomarkers.
BACKGROUND: Clinical misdiagnosis, particularly at early disease stages, is a roadblock to finding new therapies for Lewy body disorders. Biopsy of a peripheral site might provide improved diagnostic accuracy. Previously, we reported, from both autopsy and needle biopsy, a high prevalence of submandibular gland synucleinopathy in Parkinson's disease (PD). Here, we report on an extension of these studies to subjects with dementia with Lewy bodies (DLB) and other Lewy body disorders in 228 autopsied subjects from the Arizona Study of Aging and Neurodegenerative Disorders. OBJECTIVE: To provide an estimate of the prevalence of histological synucleinopathy in the submandibular glands of subjects with PD and other Lewy body disorders. METHODS: Submandibular gland sections from autopsied subjects were stained with an immunohistochemical method for α-synuclein phosphorylated at serine 129. Included were 146 cases with CNS Lewy-type synucleinopathy (LTS), composed of 46 PD, 28 DLB, 14 incidental Lewy body disease (ILBD), 33 Alzheimer's disease with Lewy bodies (ADLB) and 2 with progressive supranuclear palsy and Lewy bodies (PSPLB). Control subjects included 79 normal elderly, 15 AD, 12 PSP, 2 conticobasal degeneration (CBD) and 2 multiple system atrophy (MSA). RESULTS: Submandibular gland LTS was found in 42/47 (89%) of the PD subjects, 20/28 (71%) DLB, 4/33 (12%) ADLB and 1/9 (11%) ILBD subjects but none of the 110 control subjects. CONCLUSIONS: These results provide support for further clinical trials of in vivo submandibular gland diagnostic biopsy for PD and DLB. An accurate peripheral biopsy diagnosis would assist subject selection for clinical trials and could also be used to verify other biomarkers.
Authors: Lih-Fen Lue; Douglas G Walker; Charles H Adler; Holly Shill; Hung Tran; Haruhiko Akiyama; Lucia I Sue; John Caviness; Marwan N Sabbagh; Thomas G Beach Journal: Brain Pathol Date: 2012-04-12 Impact factor: 6.508
Authors: Charles H Adler; Brittany N Dugger; Michael L Hinni; David G Lott; Erika Driver-Dunckley; Jose Hidalgo; Jonette Henry-Watson; Geidy Serrano; Lucia I Sue; Thomas Nagel; Amy Duffy; Holly A Shill; Haruhiko Akiyama; Douglas G Walker; Thomas G Beach Journal: Neurology Date: 2014-02-05 Impact factor: 9.910
Authors: Heiko Braak; Magdalena Sastre; Jürgen R E Bohl; Rob A I de Vos; Kelly Del Tredici Journal: Acta Neuropathol Date: 2007-02-09 Impact factor: 17.088
Authors: I Litvan; C G Goetz; J Jankovic; G K Wenning; V Booth; J J Bartko; A McKee; K Jellinger; E C Lai; J P Brandel; M Verny; K R Chaudhuri; R K Pearce; Y Agid Journal: Arch Neurol Date: 1997-08
Authors: Charles H Adler; Thomas G Beach; Nan Zhang; Holly A Shill; Erika Driver-Dunckley; John N Caviness; Shyamal H Mehta; Marwan N Sabbagh; Geidy E Serrano; Lucia I Sue; Christine M Belden; Jessica Powell; Sandra A Jacobson; Edward Zamrini; David Shprecher; Kathryn J Davis; Brittany N Dugger; Joseph G Hentz Journal: J Neuropathol Exp Neurol Date: 2019-10-01 Impact factor: 3.685
Authors: Thomas G Beach; Geidy E Serrano; Thomas Kremer; Marta Canamero; Sebastian Dziadek; Hadassah Sade; Pascal Derkinderen; Anne-Gaëlle Corbillé; Franck Letournel; David G Munoz; Charles L White; Julie Schneider; John F Crary; Lucia I Sue; Charles H Adler; Michael J Glass; Anthony J Intorcia; Jessica E Walker; Tatiana Foroud; Christopher S Coffey; Dixie Ecklund; Holly Riss; Jennifer Goßmann; Fatima König; Catherine M Kopil; Vanessa Arnedo; Lindsey Riley; Carly Linder; Kuldip D Dave; Danna Jennings; John Seibyl; Brit Mollenhauer; Lana Chahine Journal: J Neuropathol Exp Neurol Date: 2018-09-01 Impact factor: 3.685